Cell ther­a­py start­up Notch Ther­a­peu­tics clos­es one of three sites

Notch Ther­a­peu­tics, an ear­ly-stage can­cer cell ther­a­py biotech, will close its Van­cou­ver lab and part ways with “some of our tal­ent­ed col­leagues,” the start­up post­ed via LinkedIn in re­cent days.

The Pa­cif­ic North­west and Cana­di­an biotech formed in 2018 with the in­tent of “in­dus­tri­al­iz­ing the pro­duc­tion of cells,” signed an off-the-shelf cell ther­a­py pact with Al­lo­gene in 2019 and then dis­closed an $85 mil­lion Se­ries A in Feb­ru­ary 2021.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.